Stay updated on Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.0%
    Check dated 2026-11-04T00:19:52.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The trial record history reflects a newer update dated 2026-10-26 covering study status and contacts/locations, alongside recent version entries dated 2026-10-21 and 2026-10-23.
    Difference
    0.1%
    Check dated 2026-10-28T00:28:35.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide NIH notice about terminology changes during a website transition appears, and the footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-21T00:23:43.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-07T00:33:25.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The Revision entry has been updated to v3.7.0, replacing the previous v3.6.6. This indicates an underlying release update to the page rather than a change to study-related content.
    Difference
    0.0%
    Check dated 2026-09-23T00:25:09.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    A new 2026-09-04 history entry including a Study Status line and the value 447 was added. The 2026-08-04 entry was deleted.
    Difference
    0.0%
    Check dated 2026-09-08T22:43:37.000Z thumbnail image

Stay in the know with updates to Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.